Quick answers
- What is Flurandrenolide used for?
- The FDA-approved label (Cordran, INA Pharmaceutics, Inc, July 7, 2025) says: “Cordran® (flurandrenolide, USP) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Flurandrenolide have a boxed warning?
- No. None of the 5 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Flurandrenolide?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Flurandrenolide been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Flurandrenolide?
- 4 companies list prescription products of Flurandrenolide in the FDA NDC Directory, including Bryant Ranch Prepack, INA Pharmaceutics Inc and Padagis Israel Pharmaceuticals Ltd.
What Flurandrenolide is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Cordran® (flurandrenolide, USP) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
— FDA label: Cordran, INA Pharmaceutics, Inc, effective July 7, 2025. Read the full label on DailyMed →
The FDA has 5 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 5 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Lotion · Cream · Tape |
|---|---|
| Route | Topical |
| Prescription products | 6 in the FDA NDC Directory |
| Brand names | Cordran |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack2 products
- INA Pharmaceutics Inc2 products
- Padagis Israel Pharmaceuticals Ltd1 product
- Almirall, LLC1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA012806 CORDRAN, CORDRAN SP | Ina Pharms | October 18, 1965 | 19, latest July 23, 2013 2013: Manufacturing (CMC) · 2013: Manufacturing (CMC) · 2012: Manufacturing (CMC) |
| NDA016455 CORDRAN | Almirall | July 29, 1969 | 12, latest January 13, 2017 2017: Manufacturing (CMC) · 2010: Manufacturing (CMC) · 2000: Manufacturing (CMC) |
Generic approvals (1)
- ANDA207133Padagis Israel · August 30, 2016
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Cordran, INA Pharmaceutics, Inc, effective July 7, 2025; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →